₹2,624.80 83.95 (3.30%)
04:01 PM, 3-Jul-2025₹2,631.50 82.60 (3.24%)
03:50 PM, 3-Jul-2025BSE : 532331
NSE : AJANTPHARM
Sector : Health care
ISIN Code : INE031B01049
Last Updated: 03-Jul-2025 | 09:31 PM IST
Market Cap (₹ Cr.) | 32,784 |
Traded Value (₹ Cr) | 2.24 |
Volume (Shares) | 8,552 |
Face Value (₹) | 2 |
52-Week High (₹) | 3,485.75 |
52-Week High Date | 12-Sep-2024 |
52-Week Low (₹) | 2,022.05 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 3,485.75 |
All Time High Date | 12-Sep-2024 |
All Time Low (₹) | 1.88 |
All Time Low Date | 01-Apr-2003 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr.) | 32,867 |
EPS - TTM (₹) [C] | 73.36 |
P/E Ratio (X) [C] | 35.87 |
Face Value (₹) | 2 |
Latest Dividend (%) | 1,400.00 |
Latest Dividend Date | 06-Nov-2024 |
Dividend Yield (%) | 1.07 |
Book Value Share (₹) [C] | 303.43 |
P/B Ratio (₹) [C] | 8.67 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Nippon India Small Cap Fund (G) | 420.43 | 16,74,471 | 0.67 |
Nippon India Small Cap Fund (IDCW) | 420.43 | 16,74,471 | 0.67 |
Nippon India Small Cap Fund (B) | 420.43 | 16,74,471 | 0.67 |
Nippon India Small Cap Fund - Direct (B) | 420.43 | 16,74,471 | 0.67 |
Nippon India Small Cap Fund - Direct (G) | 420.43 | 16,74,471 | 0.67 |
Nippon India Small Cap Fund - Direct (IDCW) | 420.43 | 16,74,471 | 0.67 |
UTI-Flexi Cap Fund (G) | 326.99 | 13,02,350 | 1.29 |
UTI-Flexi Cap Fund - Direct (G) | 326.99 | 13,02,350 | 1.29 |
Kotak Small Cap Fund (IDCW) | 306.14 | 12,19,302 | 1.77 |
Kotak Small Cap Fund (G) | 306.14 | 12,19,302 | 1.77 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
01-May-2025 | Elara Capital | Accumulate | 3,001 | |
30-Jan-2025 | Elara Capital | Accumulate | 2,930 | |
19-Sep-2024 | Edelweiss Securities | Buy | 3,665 | |
18-Sep-2024 | Edelweiss Securities | Buy | 3,665 |
Today's Low/High (₹) | 2,550.00 2,655.30 |
Week Low/High (₹) | 2,494.00 2,655.30 |
Month Low/High (₹) | 2,494.00 2,765.00 |
Year Low/High (₹) | 2,160.15 3,485.00 |
All time Low/High (₹) | 1.88 3,485.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 2.51% | 2.46% | -0.62% | -0.56% |
1 Month | 2.84% | 2.83% | 3.10% | 3.52% |
3 Month | 0.38% | 0.39% | 9.10% | 9.27% |
6 Month | -8.35% | -8.43% | 5.07% | 5.83% |
1 Year | 17.46% | 17.42% | 4.07% | 4.61% |
3 Year | 108.08% | 108.69% | 57.33% | 61.28% |
Chairman (Non-Executive) : Mannalal B Agrawal
Vice Chairman : Madhusudan B Agrawal
Managing Director : Yogesh Agrawal
Vice President & CS : Gaurang Shah
Joint Managing Director : Rajesh M Agrawal
Independent Director : David Rasquinha
Independent Director : Medha Joshi
Independent Director : Simi Thapar
Independent Director : Rajesh Shashikant Dalal
Registered Office: Ajanta House, Charkop Kandivli (W),Mumbai,Maharashtra-400067 Ph: 91-22-66061000/1204/1203
1. What's the Ajanta Pharma Ltd share price today?
Ajanta Pharma Ltd share price was Rs 2,624.80 at 04:01 PM IST on 3rd Jul 2025. Ajanta Pharma Ltd share price was up by 3.30% over the previous closing price of Rs 2,540.85. Ajanta Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Ajanta Pharma Ltd stock?
The performance of the Ajanta Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Ajanta Pharma Ltd?
Ajanta Pharma Ltd has a market capitalisation of Rs 32,784 crore.
4. What is Ajanta Pharma Ltd's 52-week high/low share price?
The Ajanta Pharma Ltd’s 52-week high share price is Rs 3,485.75 and 52-week low share price is Rs 2,022.05.
5. Is the Ajanta Pharma Ltd profitable?
On a consolidated basis, Ajanta Pharma Ltd reported a profit of Rs 225.26 crore on a total income of Rs 1,188.52 crore for the quarter ended 2025. For the year ended 2025, Ajanta Pharma Ltd had posted a profit of Rs 920.39 crore on a total income of Rs 4,648.10 crore.
6. Which are Ajanta Pharma Ltd’s peers in the Health care sector?
Ajanta Pharma Ltd’s top 5 peers in the Health care sector are Laurus Labs, Cohance Life, Ipca Labs., Ajanta Pharma, Gland Pharma, Wockhardt, Piramal Pharma.
7. Who owns how much in Ajanta Pharma Ltd?
Key changes to the Ajanta Pharma Ltd shareholding are as follows: